Pfizer Issues Birth Control Recall

Pfizer Inc. is voluntarily recalling about 1 million birth control packs after discovering that some blister packs may have the wrong number of active or inactive tablets, and that the tablets may be out of order.

Pfizer said that the error could leave women without adequate contraception and could put them at risk for unwanted pregnancy. However, the packaging defects do not pose an immediate health risk.

The drug company has identified 14 lots of Lo/Ovral tablets and 14 lots of Norgestrel and Ethinyl Estradiol tablets.

The drug company is encouraging anyone who has used the affected tablets to begin using a non-hormonal form of contraception immediately. Anyone with affected products should tell their doctor and return the package to their pharmacy.

The affected packages contain 21 active tablets and seven inactive tablets. To see the affected lot numbers, see Pfizer's website.

Pfizer said in a statement that the error was corrected immediately after it was discovered and officials have investigated the issue.

Any adverse affects that may be related to the use of these products should be reported to Akrimax Medical Information at 1-877-509-3935 from 9 a.m. to 8 p.m. Monday through Friday or to the FDA's Med Watch Program's website.